{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:47:44Z","timestamp":1792640864328,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81904319"],"award-info":[{"award-number":["81904319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001711"],"award-info":[{"award-number":["82001711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Province Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009619","name":"Guiyang Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016308","name":"Wuxi Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020203","name":"Guizhou Provincial Health and Family Planning Commission","doi-asserted-by":"publisher","award":["gzwjkj2021-106"],"award-info":[{"award-number":["gzwjkj2021-106"]}],"id":[{"id":"10.13039\/501100020203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["gyfybsky-2021-33"],"award-info":[{"award-number":["gyfybsky-2021-33"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010891","name":"Guizhou Province Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011785","name":"Science and Technology Department of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["zhukehetong202143-6"],"award-info":[{"award-number":["zhukehetong202143-6"]}],"id":[{"id":"10.13039\/501100011785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cca.2023.117443","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T08:48:47Z","timestamp":1686818927000},"page":"117443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Polymyositis and dermatomyositis biomarkers"],"prefix":"10.1016","volume":"547","author":[{"given":"Shuyue","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117443_b0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/imj.15358","article-title":"Idiopathic inflammatory myopathies: a review","volume":"51","author":"Ashton","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.cca.2023.117443_b0010","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cca.2023.117443_b0015","unstructured":"National Research Council (US) Committee on the Institutional Means for Assessment of Risks to Public Health. Risk Assessment in the Federal Government: Managing the Process. Washington (DC): National Academies Press (US); 1983."},{"issue":"2","key":"10.1016\/j.cca.2023.117443_b0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: Clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.cca.2023.117443_b0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180308","article-title":"Current Classification and Management of Inflammatory Myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.cca.2023.117443_b0030","series-title":"Clinical significance of anti MDA5 antibody in PM\/DM","author":"Ding","year":"2013"},{"issue":"1","key":"10.1016\/j.cca.2023.117443_b0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12890-021-01399-5","article-title":"Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China","volume":"21","author":"Zhan","year":"2021","journal-title":"BMC Pulm Med."},{"key":"10.1016\/j.cca.2023.117443_b0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.1780230802","article-title":"Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system","volume":"23","author":"Nishikai","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2023.117443_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42358-021-00171-x","article-title":"The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis","volume":"61","author":"de Andrade","year":"2021","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.cca.2023.117443_b0050","article-title":"Anti-PL-7 antibody-positive dermatomyositis with progressive interstitial pneumonia complicated with tracheal ulcer","volume":"33","author":"Sato","year":"2021","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.cca.2023.117443_b0055","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1111\/1346-8138.14661","article-title":"Anti-PL-12 antibody-positive antisynthetase syndrome with recurrent digital ulcers","volume":"46","author":"Miyagawa","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.cca.2023.117443_b0060","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320968417","article-title":"Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome","volume":"11","author":"Ge","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.cca.2023.117443_b0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.55563\/clinexprheumatol\/q70vmh","article-title":"Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA","volume":"40","author":"Muro","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.cca.2023.117443_b0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.autrev.2019.05.002","article-title":"Anti-OJ autoantibodies: Rare or underdetected?","volume":"18","author":"Vulsteke","year":"2019","journal-title":"Autoimmun Rev."},{"issue":"1","key":"10.1016\/j.cca.2023.117443_b0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/abd1806-4841.20186727","article-title":"Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions","volume":"93","author":"Silva","year":"2018","journal-title":"An Bras Dermatol."},{"issue":"12","key":"10.1016\/j.cca.2023.117443_b0080","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","article-title":"Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay","volume":"49","author":"Ghirardello","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2023.117443_b0085","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4161\/epi.4.8.10108","article-title":"The Mi-2\/NuRD complex: a critical epigenetic regulator of hematopoietic development, differentiation and cancer","volume":"4","author":"Ram\u00edrez","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.cca.2023.117443_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0090-1229(76)90145-8","article-title":"Description of a serological reaction characteristic of polymyositis","volume":"5","author":"Reichlin","year":"1976","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.cca.2023.117443_b0095","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","article-title":"The association between Mi-2 antibodies and dermatomyositis","volume":"28","author":"Targoff","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2023.117443_b0100","article-title":"Pathologic Features of Anti-Mi-2 Dermatomyositis","author":"Tanboon","year":"2023","journal-title":"Neurology 2021;96:e448\u201359. Erratum Neurology"},{"key":"10.1016\/j.cca.2023.117443_b0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1684\/ejd.2020.3750","article-title":"Anti\u2013Mi\u20132 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis","volume":"30","author":"Liang","year":"2020","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.cca.2023.117443_b0110","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117443_b0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coviro.2015.01.011","article-title":"MDA5-filament, dynamics and disease","volume":"12","author":"del Toro","year":"2015","journal-title":"Curr Opin Virol."},{"issue":"9","key":"10.1016\/j.cca.2023.117443_b0120","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.cca.2023.117443_b0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/imj.14789","article-title":"Anti-MDA5-associated dermatomyositis","volume":"50","author":"Gupta","year":"2020","journal-title":"Intern Med J."},{"issue":"12","key":"10.1016\/j.cca.2023.117443_b0130","article-title":"Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies","volume":"20","author":"Nombel","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.cca.2023.117443_b0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11926-018-0798-1","article-title":"Anti-MDA5 Antibody Spectrum in Western World","volume":"20","author":"Moghadam-Kia","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.cca.2023.117443_b0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","article-title":"Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis","volume":"60","author":"Wu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cca.2023.117443_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845988","article-title":"Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome","volume":"13","author":"Zuo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117443_b0150","article-title":"ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis","volume":"12","author":"Matsuo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117443_b0155","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2023.117443_b0160","article-title":"Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1\u03b3 Antibody-Positive Dermatomyositis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117443_b0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/25785826.2020.1791402","article-title":"Transcriptional intermediary factor 1 (TIF1) and anti-TIF1\u03b3 antibody-positive dermatomyositis","volume":"44","author":"Kotobuki","year":"2021","journal-title":"Immunol Med"},{"key":"10.1016\/j.cca.2023.117443_b0170","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/rheumatology\/kez527","article-title":"Pregnancy triggers the onset of anti-transcriptional intermediary factor 1\u03b3 antibody-positive dermatomyositis: a case series","volume":"59","author":"Oya","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2023.117443_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.804037","article-title":"A Commercial Anti-TIF1\u03b3 ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing","volume":"13","author":"Mulhearn","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117443_b0180","first-page":"S139","article-title":"Clinical and serological characterization of the anti-MJ antibody in childhood myositis abstract","volume":"40","author":"Oddis","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117443_b0185","first-page":"S787","article-title":"Sera with autoantibodies to the MJ antigen react with NXP2 abstract","volume":"56","author":"Targoff","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117443_b0190","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1007\/s10067-021-05667-x","article-title":"Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody","volume":"40","author":"Yan","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.cca.2023.117443_b0195","doi-asserted-by":"crossref","first-page":"394","DOI":"10.55563\/clinexprheumatol\/56ilob","article-title":"Juvenile dermatomyositis. Where are we now?","volume":"40","author":"McCann","year":"2022","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.cca.2023.117443_b0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12969-020-00492-z","article-title":"Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children","volume":"19","author":"Wang","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.cca.2023.117443_b0205","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/rheumatology\/kez083","article-title":"FDG-PET detects extensive calcinosis cutis in anti-NXP2 antibody-positive dermatomyositis","volume":"58","author":"Nakamura","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2023.117443_b0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12969-020-00486-x","article-title":"Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature","volume":"19","author":"Xu","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.cca.2023.117443_b0215","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1684\/ejd.2020.3858","article-title":"A case of anti-NXP2 antibody-positive dermatomyositis with improvement of clinical symptoms and disappearance of autoantibody after resection of uterine cancer","volume":"30","author":"Fushida","year":"2020","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.cca.2023.117443_b0220","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/art.22862","article-title":"Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis","volume":"56","author":"Betteridge","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2023.117443_b0225","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s10067-019-04562-w","article-title":"Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review","volume":"38","author":"Jia","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2023.117443_b0230","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/jcm8010020","article-title":"Heart-Lung-Muscle Anti-SAE Syndrome: An Atypical Severe Combination","volume":"8","author":"Zamora","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.cca.2023.117443_b0235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41598-017-00240-6","article-title":"Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts","volume":"7","author":"Ge","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cca.2023.117443_b0240","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"333\u2013335","key":"10.1016\/j.cca.2023.117443_b0245","first-page":"341","article-title":"Characteristics of idiopathic inflammatory myopathy with positive anti-HMGCr\/SRP antibody","volume":"14","author":"Zeng","year":"2019","journal-title":"Neural Injury and Functional Reconstruction"},{"key":"10.1016\/j.cca.2023.117443_b0250","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cca.2023.117443_b0255","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12872-021-01900-2","article-title":"Immunotherapy reversed myopathy but not cardiomyopathy in a necrotizing autoimmune myopathy patient with positive anti-SRP and MDA-5 autoantibodies","volume":"21","author":"Ma","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cca.2023.117443_b0260","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.mayocp.2020.03.032","article-title":"Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy","volume":"95","author":"Triplett","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cca.2023.117443_b0265","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5692\/clinicalneurol.cn-001684","article-title":"A case of anti-SRP antibody-positive immune-mediated necrotizing myopathy triggered by human parvovirus B19 infection","volume":"62","author":"Suzuki","year":"2022","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.cca.2023.117443_b0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijid.2020.11.153","article-title":"Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report","volume":"103","author":"Iriki","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cca.2023.117443_b0275","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.2169\/internalmedicine.0404-22","article-title":"Anti-signal Recognition Particle Antibody-positive Immune-mediated Myopathy after mRNA-1273 SARS-CoV-2 Vaccination","volume":"61","author":"Tanemoto","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.cca.2023.117443_b0280","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/rheumatology\/keab846","article-title":"Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis","volume":"61","author":"Karasawa","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2023.117443_b0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0004563218786979","article-title":"Elevated serum YKL-40 correlates with clinical characteristics in patients with polymyositis or dermatomyositis","volume":"56","author":"Gao","year":"2019","journal-title":"Ann Clin Biochem"},{"issue":"9","key":"10.1016\/j.cca.2023.117443_b0290","doi-asserted-by":"crossref","first-page":"e24605","DOI":"10.1002\/jcla.24605","article-title":"Clinical value of YKL-40 in patients with polymyositis\/dermatomyositis: A cross-sectional study and a systematic review","volume":"36","author":"Cui","year":"2022","journal-title":"J Clin Lab Anal."},{"key":"10.1016\/j.cca.2023.117443_b0295","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.autrev.2017.07.021","article-title":"Using multi-omics methods to understand dermatomyositis\/polymyositis","volume":"16","author":"Gao","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2023.117443_b0300","doi-asserted-by":"crossref","first-page":"1920111","DOI":"10.1155\/2021\/1920111","article-title":"Identification of Latent Diagnostic Biomarkers and Biological Pathways in Dermatomyositis Based on WGCNA","volume":"2021","author":"Ouyang","year":"2021","journal-title":"J Oncol"},{"key":"10.1016\/j.cca.2023.117443_b0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fimmu.2020.00037","article-title":"Reduced miR-146a Promotes REG3A Expression and Macrophage Migration in Polymyositis and Dermatomyositis","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117443_b0310","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1089\/jir.2019.0063","article-title":"Interleukin-35: A Serological Biomarker for Patients with Polymyositis\/Dermatomyositis","volume":"39","author":"Jiang","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.cca.2023.117443_b0315","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1080\/14397595.2019.1661584","article-title":"miR-1 is a novel biomarker for polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"30","author":"Sugiyama","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.cca.2023.117443_b0320","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/joim.13154","article-title":"IL-15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis\/dermatomyositis","volume":"289","author":"Shimizu","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.cca.2023.117443_b0325","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.41566","article-title":"Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis\/Dermatomyositis-Associated Interstitial Lung Disease","volume":"73","author":"Gono","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cca.2023.117443_b0330","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/rheumatology\/keab588","article-title":"Identification of plexin D1 on circulating extracellular vesicles as a potential biomarker of polymyositis and dermatomyositis","volume":"61","author":"Uto","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2023.117443_b0335","article-title":"Elevation of serum tenascin-C levels in dermatomyositis patients [published online ahead of print, 2023 Mar 14]","author":"Nishiwaki","year":"2023","journal-title":"Int J Rheum Dis."},{"issue":"6","key":"10.1016\/j.cca.2023.117443_b0340","doi-asserted-by":"crossref","first-page":"e24876","DOI":"10.1002\/jcla.24876","article-title":"Low serum level of citrullinated histone H3 in patients with dermatomyositis","volume":"37","author":"Wang","year":"2023","journal-title":"J Clin Lab Anal."},{"key":"10.1016\/j.cca.2023.117443_b0345","doi-asserted-by":"crossref","unstructured":"Kry\u0161t\u016ffkov\u00e1 O, Hulejov\u00e1 H, Mann HF, et al. Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis. Arthritis Res Ther. 2018;20(1):158. Published 2018 Jul 27.","DOI":"10.1186\/s13075-018-1650-8"},{"issue":"8","key":"10.1016\/j.cca.2023.117443_b0350","doi-asserted-by":"crossref","first-page":"e0161436","DOI":"10.1371\/journal.pone.0161436","article-title":"HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis \/Dermatomyositis with Interstitial Lung Disease","volume":"11","author":"Shu","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cca.2023.117443_b0355","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3899\/jrheum.170997","article-title":"Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases","volume":"45","author":"Kawasumi","year":"2018","journal-title":"J Rheumatol."},{"issue":"10","key":"10.1016\/j.cca.2023.117443_b0360","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.21037\/apm-22-604","article-title":"Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis\/dermatomyositis","volume":"11","author":"Ha","year":"2022","journal-title":"Ann Palliat Med."},{"issue":"1","key":"10.1016\/j.cca.2023.117443_b0365","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1038\/s41598-022-09943-x","article-title":"The SNPs of mitochondrial DNA displacement loop region and mitochondrial DNA copy number associated with risk of polymyositis and dermatomyositis","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.cca.2023.117443_b0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acs.jproteome.2c00532","article-title":"Proteomics Analysis of Plasma-Derived Exosomes Unveils the Aberrant Complement and Coagulation Cascades in Dermatomyositis\/Polymyositis","volume":"22","author":"Meng","year":"2023","journal-title":"J Proteome Res."},{"key":"10.1016\/j.cca.2023.117443_b0375","doi-asserted-by":"crossref","first-page":"e22209","DOI":"10.1002\/jcla.22209","article-title":"Red blood cell distribution width and neutrophil to lymphocyte ratio are correlated with disease activity of dermatomyositis and polymyositis","volume":"32","author":"Gao","year":"2018","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"10.1016\/j.cca.2023.117443_b0380","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.advms.2022.08.005","article-title":"Thrombin generation potential is increased in patients with autoimmune inflammatory myopathies","volume":"67","author":"Kuszmiersz","year":"2022","journal-title":"Adv Med Sci."},{"issue":"10","key":"10.1016\/j.cca.2023.117443_b0385","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.18632\/aging.204098","article-title":"Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis","volume":"14","author":"Chen","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.cca.2023.117443_b0390","doi-asserted-by":"crossref","first-page":"309","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo","year":"2022","journal-title":"Clin Exp Rheumatol."},{"issue":"3","key":"10.1016\/j.cca.2023.117443_b0395","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1111\/1346-8138.16249","article-title":"Case of anti-Mi-2 antibody-positive dermatomyositis with predictable onset before the development of muscle symptoms","volume":"49","author":"Kaneda","year":"2022","journal-title":"J Dermatol."},{"issue":"2","key":"10.1016\/j.cca.2023.117443_b0400","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3899\/jrheum.220139","article-title":"Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk","volume":"50","author":"Lv","year":"2023","journal-title":"J Rheumatol."},{"issue":"3","key":"10.1016\/j.cca.2023.117443_b0405","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10067-022-06425-3","article-title":"Circulating VEGF-A, TNF-\u03b1, CCL2, IL-6, and IFN-\u03b3 as biomarkers of cancer in cancer-associated anti-TIF1-\u03b3 antibody-positive dermatomyositis","volume":"42","author":"Li","year":"2023","journal-title":"Clin Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2023.117443_b0410","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12969-020-00486-x","article-title":"Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature","volume":"19","author":"Xu","year":"2021","journal-title":"Pediatr Rheumatol Online J."},{"key":"10.1016\/j.cca.2023.117443_b0415","first-page":"kead154","article-title":"Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature [published online ahead of print, 2023 Apr 3]","author":"Demortier","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.cca.2023.117443_b0420","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1007\/s10067-021-05797-2","article-title":"Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology","volume":"40","author":"G\u00f3mez","year":"2021","journal-title":"Clin Rheumatol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123002450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123002450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:04:37Z","timestamp":1762113877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123002450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":84,"alternative-id":["S0009898123002450"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117443","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymyositis and dermatomyositis biomarkers","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117443"}}